<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="correction"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25268802</article-id><article-id pub-id-type="pmc">4182631</article-id><article-id pub-id-type="publisher-id">PONE-D-14-41950</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0110069</article-id><article-categories><subj-group subj-group-type="heading"><subject>Correction</subject></subj-group></article-categories><title-group><article-title>Correction: Pharmacodynamic Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, from a Randomized Study in Patients with Type 2 Diabetes</article-title></title-group><contrib-group><contrib contrib-type="author"><collab>The <italic>PLOS ONE</italic> Staff</collab></contrib></contrib-group><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>30</day><month>9</month><year>2014</year></pub-date><pub-date pub-type="pmc-release"><day>30</day><month>9</month><year>2014</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>9</volume><issue>9</issue><elocation-id>e110069</elocation-id><permissions><copyright-statement>&#x000a9; 2014 The PLOS ONE Staff</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>The PLOS ONE Staff</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><related-article id="d35e64" related-article-type="corrected-article" ext-link-type="doi" xlink:href="10.1371/journal.pone.0105638" page="e105638">
<article-title>Pharmacodynamic Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, from a Randomized Study in Patients with Type 2 Diabetes</article-title>
</related-article><counts><page-count count="1"/></counts></article-meta></front><body><sec id="s1"><title>Notice of Republication</title><p>This article was republished on September 15, 2014, to correct typesetting errors involving missing minus symbols throughout the text and tables. The publisher apologizes for these errors. Please download this article again to view the article. The originally published, uncorrected article and the republished, corrected article are provided here for reference.</p></sec><sec sec-type="supplementary-material" id="s2"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0110069.s001"><label>File S1</label><caption><p>
<bold>Originally published, uncorrected article</bold>
</p><p>PDF</p></caption><media xlink:href="pone.0110069.s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0110069.s002"><label>File S2</label><caption><p>
<bold>Republished, corrected article</bold>
</p><p>PDF</p></caption><media xlink:href="pone.0110069.s002.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ref-list><title>Reference</title><ref id="pone.0110069-Sha1"><label>1</label><mixed-citation publication-type="journal">
<name><surname>Sha</surname><given-names>S</given-names></name>, <name><surname>Devineni</surname><given-names>D</given-names></name>, <name><surname>Ghosh</surname><given-names>A</given-names></name>, <name><surname>Polidori</surname><given-names>D</given-names></name>, <name><surname>Hompesch</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Pharmacodynamic Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, from a Randomized Study in Patients with Type 2 Diabetes</article-title>. <source>PLoS ONE</source>
<volume>9(8)</volume>: <fpage>e105638</fpage>
<comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0105638">10.1371/journal.pone.0105638</ext-link></comment>
<pub-id pub-id-type="pmid">25166023</pub-id></mixed-citation></ref></ref-list></back></article>